相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of COVID-19 and lockdowns on pulmonary embolism in hospitalized patients in France: a nationwide study
Pierre Tankere et al.
RESPIRATORY RESEARCH (2021)
Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register
Emilia Antonucci et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
Faizan Khan et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism
Stavros V. Konstantinides et al.
EUROPEAN HEART JOURNAL (2019)
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants
S. Testa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
External validation of the DASH prediction rule: a retrospective cohort study
A. Tosetto et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens
Javier Trujillo-Santos et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
D-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy A Cohort Study
Clive Kearon et al.
ANNALS OF INTERNAL MEDICINE (2015)
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism The PADIS-PE Randomized Clinical Trial
Francis Couturaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation
Paolo Prandoni et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Duration of anticoagulation after venous thromboembolism in real world clinical practice
Walter Ageno et al.
THROMBOSIS RESEARCH (2015)
Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes
Jan Beyer-Westendorf et al.
THROMBOSIS RESEARCH (2015)
Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands
Susan Hanemaaijer et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2015)
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study
Gualtiero Palareti et al.
BLOOD (2014)
Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban
Inna Y. Gong et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Apixaban for Extended Treatment of Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
Florent Boutitie et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of D-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism
James Douketis et al.
ANNALS OF INTERNAL MEDICINE (2010)
Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism
Madeleine Verhovsek et al.
ANNALS OF INTERNAL MEDICINE (2008)
Thrombophilia, clinical factors, and recurrent venous thrombotic events
SC Christiansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
High risk of recurrent venous thromboembolism in men
T Baglin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis.
G Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
